Navigation Links
Lilly and Investor Group Form New Critical Care Company BioCritica, Sign Xigris License Agreement
Date:5/23/2011

contraindicated in the following clinical situations where bleeding could lead to significant morbidity or death:

  • Active internal bleeding
  • Recent (within 3 months) hemorrhagic stroke
  • Recent (within 2 months) intracranial or intraspinal surgery, or severe head trauma
  • Trauma with an increased risk of life-threatening bleeding
  • Presence of an epidural catheter
  • Intracranial neoplasm or mass lesion or evidence of cerebral herniation

WARNINGS and PRECAUTIONS

Bleeding is the most common serious adverse effect associated with Xigris therapy. Each patient being considered for therapy with Xigris should be carefully evaluated and anticipated benefits weighed against potential risks associated with therapy.

Certain conditions, many of which led to exclusion from the Phase 3 clinical trial (PROWESS), are likely to increase the risk of bleeding with Xigris therapy. Therefore, for patients with severe sepsis who have one or more of the following conditions, the increased risk of bleeding should be carefully considered when deciding whether to use Xigris therapy:

  • Concurrent therapeutic dosing of heparin to treat an active thrombotic or embolic event
  • Platelet count <30,000 x 10,000,000/L, even if the platelet count is increased after transfusions
  • Prothrombin time-INR >3.0
  • Recent (within 6 weeks) gastrointestinal bleeding
  • Recent administration (within 3 days) of thrombolytic therapy
  • Recent administration (within 7 days) of oral anticoagulants or glycoprotein IIb/IIIa inhibitors
  • Recent administration (within 7 days) of aspirin >650 mg per day or other platelet inhibitors
  • Recent (within 3 months) ischemic stroke
  • Intracranial arteriovenous malformation or aneurysm
  • Known bleeding diathesis
  • Chronic severe hepatic disease '/>"/>

SOURCE Eli Lilly and Company
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Study Determined Best Dose and Showed 55 Percent Response Rate With Lilly Anti-BAFF Monoclonal Antibody in Previously-Treated Multiple Myeloma Patients
2. David M. Kendall, M.D., Named Distinguished Medical Fellow at Lilly
3. Lilly Provides Its Perspective in Response to Amylin Lawsuit
4. Lilly Provides Statement in Response to Amylin Lawsuit
5. Lilly USA, LLC Launches TruAssist for Patients
6. Lilly Oncology to Unveil Data From More Than 30 Studies at ASCO
7. Lilly Oncology to Present New Data on Nine of Its Pipeline Molecules at ASCO 2011
8. Amylin Pharmaceuticals Files Suit Against Eli Lilly
9. Eli Lilly and Company Invests $2.5 Million to Launch The Mind Trusts Grow What Works Campaign
10. U.S. District Court Order Maintains Patent Exclusivity for Lillys Cymbalta
11. Lilly and Medtronic Announce Drug-Device Collaboration for Parkinsons Disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/19/2014)... 2014  RESMED INC. (NYSE: RMD ) today ... year 2015 results on Thursday, January 22, 2015, after the ... ResMed,s results will be issued after 1:00 p.m. US Pacific ... operating results and future outlook. The earnings call ... and the live webcast of the call can be accessed ...
(Date:12/19/2014)... 18, 2014 Since last month,s FBI shutdown ... known as the leading online black market for illegal ... in its offering of drugs and other illegal items.  ... takedowns did succeed in lowering the numbers of drugs ... the markets in August. But some new sites that ...
(Date:12/19/2014)... France , Dec. 19, 2014  Eli Lilly ... (Euronext Paris: FR0011184241 – ADOC) today announced a worldwide ... as BioChaperone Lispro, for treatment in people with type ... Adocia,s proprietary BioChaperone® technology and is currently in Phase ... BioChaperone Lispro with the goal of optimizing glucose levels ...
Breaking Medicine Technology:ResMed To Announce Second Quarter 2015 Results 2Post Silk Road - Another Online Drug Den Now Dominates the DarkNet 2Post Silk Road - Another Online Drug Den Now Dominates the DarkNet 3Lilly and Adocia Announce Alliance to Co-Develop Ultra-Rapid Insulin Based on BioChaperone Technology 2Lilly and Adocia Announce Alliance to Co-Develop Ultra-Rapid Insulin Based on BioChaperone Technology 3
(Date:12/19/2014)... 2014 This is a professional and ... Gliquidone industry with a focus on the Chinese market. ... of the Gliquidone manufacturers and is a valuable source ... in the industry. , Firstly, the report provides a ... and manufacturing technology. Then, the report explores the international ...
(Date:12/19/2014)... -- The tragic death from "rat-bite fever" of a 10-year-old ... rodents, according to a report from the U.S. Centers for ... but potentially fatal illness that should be considered in persons ... of rodent exposure is reported," said a team led by ... The case outlined in the report occurred in August of ...
(Date:12/19/2014)... Steven Reinberg HealthDay Reporter ... can,t balance on one leg for at least 20 seconds ... suggest. Difficulty standing on one leg may indicate that ... the risk for more serious strokes is high, the investigators ... "Individuals showing instability while standing on one leg, as ...
(Date:12/17/2014)... HeartMath® Inc., recognized as one of the world’s ... heart coherence and the physiology of emotions, is ... to chipset manufacturers and consumer electronics companies. The ... its HRV solutions, tap into its HRV sensor ... HRV databases and algorithms for developing consumer products. ...
(Date:12/17/2014)... NY (PRWEB) December 17, 2014 Project ... who recently brought videos of MIT economist and Obamacare ... best-selling author James O’Keefe conducted the interview, which is ... stated that there was intentional mislabeling in the Affordable ... in the bill: A two-hundred-and-fifty billion dollar per year ...
Breaking Medicine News(10 mins):Health News:Gliquidone Industry Global and China Analysis for 2019, Now Available at ReportsnReports.com 2Health News:Gliquidone Industry Global and China Analysis for 2019, Now Available at ReportsnReports.com 3Health News:Gliquidone Industry Global and China Analysis for 2019, Now Available at ReportsnReports.com 4Health News:Gliquidone Industry Global and China Analysis for 2019, Now Available at ReportsnReports.com 5Health News:Gliquidone Industry Global and China Analysis for 2019, Now Available at ReportsnReports.com 6Health News:Scratch From Pet Rat Kills Child; CDC Warns of Risk 2Health News:Can You Balance on One Leg? You May Have Lower Stroke Risk 2Health News:HeartMath® Inc.’s HRV Platform Solutions Available for Licensing 2Health News:HeartMath® Inc.’s HRV Platform Solutions Available for Licensing 3Health News:Project Veritas: James O’Keefe Interviews the Man Who Discovered Jonathan Gruber Videos 2
... PHILADELPHIA, July 17 , , WHO: ... members of a crisis management team assisting clients ... in Jakarta,s Mega Kuningan business district., WHY: International SOS ... of medical, security, aviation, logistical and communications, ...
... children and young adults still primary targets, , FRIDAY, July ... development of a vaccine for the H1N1 swine flu is ... fall. , Initial tests of a vaccine are expected to ... and effectiveness won,t be known for about month after that, ...
... , , WASHINGTON, July 17 ... Fla., has agreed to pay the United States $1.7 million to ... Justice announced today. , , In ... Middle District of Florida, United States ex rel. Michael Flanery ...
... , WASHINGTON, July 17 The Food and Drug ... Series -- Price Reporting Basics under Medicaid, Medicare and the ... , Written by Alice Valder Curran, ... two associates at the firm, Emily S. Gebba and Sarah H. ...
... to patients, poor emotional status, study suggests , FRIDAY, ... a positive religious attitude is not linked to measures ... can lead to worse emotional and mental health, a ... with early-stage breast cancer and 86 women with late-stage ...
... , , , , ... and how best to prepare for ... ROSEMONT, Ill., July 17 Pope Benedict XVI,s fractured wrist . ... Boys of Summer. If you need an expert to discuss any of these timely ...
Cached Medicine News:Health News:Available for Interviews: Doctor, Security Specialist Assisting Victims of Jakarta Bombings 2Health News:Available for Interviews: Doctor, Security Specialist Assisting Victims of Jakarta Bombings 3Health News:Available for Interviews: Doctor, Security Specialist Assisting Victims of Jakarta Bombings 4Health News:Swine Flu Vaccine on Track for Fall: CDC 2Health News:Swine Flu Vaccine on Track for Fall: CDC 3Health News:Swine Flu Vaccine on Track for Fall: CDC 4Health News:Swine Flu Vaccine on Track for Fall: CDC 5Health News:Swine Flu Vaccine on Track for Fall: CDC 6Health News:Swine Flu Vaccine on Track for Fall: CDC 7Health News:Swine Flu Vaccine on Track for Fall: CDC 8Health News:Swine Flu Vaccine on Track for Fall: CDC 9Health News:Swine Flu Vaccine on Track for Fall: CDC 10Health News:Swine Flu Vaccine on Track for Fall: CDC 11Health News:Swine Flu Vaccine on Track for Fall: CDC 12Health News:Tampa Bay Doctor Agrees to Pay United States $1.7 Million to Resolve Medicare Fraud Allegations 2Health News:New FDLI Monograph on Federal Price Reporting Requirements Provides Essential Guidance on Commercial Strategy, Compliance Issues 2Health News:Spiritual Outlook Can Affect Mental Health in Breast Cancer 2Health News:Writing About Injuries or Surgeries? 2
Micro-mini fiber optic light....
Xenon technology achieves a higher efficiency than halogen light sources. Consequently they provide more light....
The 300W effective dual light source has quality xenon performance....
Cold light source single outlet....
Medicine Products: